QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NVST

QT68Envista Holdings Corp
NYSE·Healthcare·Medical - Equipment & Services·USA
Latest market price
25.91
+1.05+4.22%
OverviewShort InterestFilings
NVSTQT68Envista Holdings Corp·NYSE
OverviewShort InterestFilings
25.91+4.22%
TA
Loading chart...
Screen all →
HIMS+11.23%$35.47CON+0.63%$28.56BBNX+5.23%$13.88
Snapshot
Index-P/E60.19EPS (ttm)0.41Insider Own1.83%Shs Outstand162.73MPerf Week
5.76%
Market Cap4.05BForward P/E16.48EPS next Y1.57Insider Trans0.01%Shs Float-Perf Month12.41%
Enterprise Value4.55BPEG0.34EPS next Q0.33Inst Own-Short Float-Perf Quarter2.57%
Income67.15MP/S1.44EPS this Y249.31%Inst Trans-Short Ratio-Perf Half Y18.31%
Sales2.81BP/B1.32EPS next Y9.75%ROA1.21%Short Interest-Perf YTD19.35%
Book/sh18.93P/C14.97EPS next 5Y9.98%ROE2.18%52W High30.42 -14.83%Perf Year40.59%
Cash/sh6.66P/FCF18.37EPS past 3/5Y-ROIC1.78%52W Low18.25 41.97%Perf 3Y-
Dividend Est.-EV/EBITDA13.13Sales past 3/5Y1.92% 7.11%Gross Margin55.14%Volatility2.96% 2.44%Perf 5Y-
Dividend TTM-EV/Sales1.62EPS Y/Y TTM120.31%Oper. Margin9.04%ATR (14)0.88Perf 10Y-
Dividend Ex-Date-Quick Ratio2.06Sales Y/Y TTM11.87%Profit Margin2.41%RSI (14)65.65Recom2.71
Dividend Gr. 3/5Y-Current Ratio2.44EPS Q/Q50.00%SMA208.60%Beta1.40Target Price28.33
Payout0.00%Debt/Eq0.52Sales Q/Q14.42%SMA503.57%Rel Volume1.24Prev Close24.86
Employees12,300LT Debt/Eq0.50EarningsAug 05SMA20010.45%Avg Volume3.15MPrice25.91
IPO DateSep 18, 2019Option/ShortYes / YesEPS/Sales Surpr.16.13% 3.82%Net Debt/EBITDA1.46Volume3,901,393Change4.22%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26ReiteratedBarclaysOverweight$24 → $32
May-07-26ReiteratedEvercore ISI$30 → $33
May-07-26ReiteratedRobert W. Baird$30 → $31
Apr-08-26ReiteratedEvercore ISI$32 → $30
Feb-06-26ReiteratedRobert W. Baird$27 → $30
Feb-06-26ReiteratedMorgan StanleyEqual Weight$18 → $19
Feb-06-26ReiteratedEvercore ISI$26 → $32
Feb-06-26ReiteratedStifel NicolausBuy$27 → $31
Feb-06-26ReiteratedLeerink PartnersMarket Perform$23 → $35
Feb-06-26ReiteratedPiper SandlerNeutral$21 → $25
Latest News
Jun-11-26
Jun-11-2610:46AM
Barclays Maintains Overweight on Envista Holdings, Lowers Price Target to $32Benzinga
10:46AM
Barclays Maintains Overweight on Envista Holdings, Lowers Price Target to $32Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,8092,7202,511
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,2601,2231,119
Gross Profit1,5481,4961,392
Selling, General and Administrative Excl. Other1,1761,1571,136
Research and Development11811499
Other Operating Expense001,195
Operating Income255226-1,038
Interest Expense203746
Unusual Expense
———
Non-Operating Income (Expense)3412-1,195
Net Income Before Taxes201177-1,085
Income Taxes13313034
Consolidated Net Income6847-1,119
Net Income From Continuing Operations6847-1,119
Net Income6847-1,119
EPS (Recurring)0.420.28-6.50
EPS (Basic, Before Extraordinaries)0.420.28-6.50
EPS (Diluted)0.410.28-6.50
EBITDA347330280
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio63.2077.54—
Price To Sales Ratio1.511.34—
Gross Margin55.1155.0055.44
Operating Margin9.088.31-41.34
Net Margin2.421.73-44.56
Shares Outstanding164168172
Market Capitalization4,2493,647—
Operating Lease Expense
———
Insider Trading Volume
$28.28$25.92$23.55$21.19$18.83● Close Price0.00K81.00K162.00K243.00K324.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Option Exercise17.2519,350333,83238,016Feb 11 12:00 AM
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Sale30.005,634169,02032,382Feb 11 12:00 AM
Reis MischaSVP, Strategy & Bus. Dev.Aug 25 '25Sale21.6015,000324,00032,382Aug 27 12:00 AM
Keel Paul AChief Executive OfficerAug 13 '24Buy16.8730,000506,100402,605Aug 14 12:00 AM
Hammes Eric D.Chief Financial OfficerAug 12 '24Buy16.3324,532400,60824,532Aug 13 12:00 AM
Conley EricSVP, OrthodonticsNov 16 '23Buy22.892,18550,01547,376Nov 20 12:00 AM
Nance Mark EGeneral CounselNov 08 '23Buy21.755,000108,75039,042Nov 09 12:00 AM
Aghdaei AmirChief Executive OfficerNov 06 '23Buy21.5310,000215,254295,362Nov 07 12:00 AM
Keller StephenPrincipal Financial OfficerNov 06 '23Buy21.532,00043,06013,070Nov 07 12:00 AM
Yu Howard HChief Financial OfficerFeb 28 '23Sale37.9010,016379,60645,865Mar 01 12:00 AM
Yu Howard HChief Financial OfficerNov 17 '22Sale36.5565724,01351,106Nov 21 12:00 AM
Yu Howard HChief Financial OfficerApr 18 '22Sale45.735,341244,24452,411Apr 20 12:00 AM
Aghdaei AmirChief Executive OfficerMar 29 '22Sale51.503,801195,752364,779Mar 31 12:00 AM
Yu Howard HChief Financial OfficerMar 21 '22Option Exercise21.766,716146,14159,682Mar 22 12:00 AM
Yu Howard HChief Financial OfficerMar 18 '22Option Exercise21.7642,360921,75577,504Mar 22 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR